权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Role of HIV in acceleration of HPV malignancy

HIV 在加速 HPV 恶性肿瘤中的作用

基本信息

批准号：
10521250
负责人：
SHAROF M TUGIZOV
金额：
$ 36.94万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-12-01 至 2024-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10521250
关键词：
Acceleration Adherence Adherens Junction Anogenital cancer Anus Back Binding Biopsy CCR5 gene CD4 Positive T Lymphocytes CXCR4 gene Cell Adhesion Cell Differentiation process Cell Proliferation Cells Cervical Cervix Uteri Chemosensitization Data Dendritic Cells Development Disease E-Cadherin Embryonic Development Epigenetic Process Epithelial Cells Epithelium Gelatinase A Goals HIV HIV Envelope Protein gp120 HIV Infections HIV Seronegativity HIV Seropositivity HIV therapy HPV oropharyngeal cancer Human Papilloma Virus-Related Malignant Neoplasm Human Papillomavirus Human papillomavirus 16 Immune response Incidence Individual Inflammatory Integrins Interferon Type II Interferons Invaded Knowledge Lead Macrophage Malignant neoplasm of anus Malignant neoplasm of cervix uteri Mediating Mesenchymal Molecular Mucous Membrane Neoplasms Neoplastic Processes Normal tissue morphology Oncoproteins Oral Oropharyngeal Papillomavirus Transforming Protein E6 Pathway interactions Penetration Phenotype Play Prevention approach Process Proliferating Proteins Public Health Publishing Research Risk Role Squamous intraepithelial lesion TNF gene TNFRSF1A gene Tight Junctions Tissues Tonsil Up-Regulation Vimentin Viral Work antiretroviral therapy attenuation cell motility cell transformation cytokine epithelial to mesenchymal transition keratinocyte migration monocyte novel strategies novel therapeutics oral cavity epithelium premalignant protein E receptor restoration synergism tat Protein tissue culture tumor progression

项目摘要

Project summary/Abstract Accumulating evidence indicates that the incidence of HPV-associated neoplasia in HIV-positive individuals is substantially higher than in HIV-negative individuals despite effective antiretroviral therapy. These data strongly suggest that HIV may play a critical role in development of HPV-associated neoplasia of the anus, cervix and oropharyngeal cavity. However the mechanisms by which it does so are poorly understood. Our published work and preliminary data show that HIV may interact with oral and anal epithelia creating a tissue microenvironment where epithelial cells lose tight and adherence junctions. These epithelia have multiple changes consistent with epithelial-mesenchymal transition (EMT), a multistep epigenetic process characterized by loss of cell adhesion and increased mobility of epithelial cells. EMT is important in cell differentiation during embryogenesis but also plays a critical role in neoplastic progression. Our data show that oral and anal mucosal epithelial biopsies obtained from HIV-infected individuals show typical signs of EMT, i.e., the adherens junction protein E-cadherin is down-regulated and vimentin expression is up-regulated. Exposure of tonsil epithelial cells from HIV-uninfected individuals to HIV tat and gp120 proteins leads to induction of EMT. Additionally we observed that HIV infection is associated with elevation of proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) in mucosal epithelia, which may also be involved in induction of EMT. Finally, it is known that HPV oncoproteins E6/E7 can induce the EMT phenotype. Thus, there are several pathways through which HIV and HPV may interact with mucosal epithelia, and may synergize to establish EMT with consequent potentiation of HPV-associated neoplasia. In general the EMT phenotype is reversible and EMT cells may transition back and forth between EMT and the normal state, a process known as mesenchymal-epithelial transition (MET). Induction of MET or inhibition of EMT may represent a novel approach to prevention and treatment of HPV-associated oropharyngeal, cervical and anal neoplasia and may be a novel approach to reducing the high incidence of HPV-associated malignancy in HIV- infected individuals. Accordingly, our specific aims are: (1) To investigate mechanisms of HIV-associated EMT in cervical and anal mucosal epithelial cells and induction of MET in these cells by suppression of vimentin and upregulation of E-cadherin expression, (2) To investigate synergy between HIV and HPV in development of the EMT phenotype, and (3) To study the role of suppression of HIV- and HPV- induced EMT and activation of MET in the reduction of HPV-associated cervical and anal cell transformation and invasion. Knowledge generated through this work will be of great value to understanding the mechanisms by which HIV and HPV interact to potentiate development of HPV-associated epithelial neoplasia. This knowledge may also lead to development of compounds that may be useful for treatment of HPV-associated cancers and pre-cancers in the setting of HIV infection through inhibition of HIV/HPV-induced EMT and activation of MET.

项目总结/文摘